People · Operator
Named in public records as an officer, director or promoter · active 2018–2018 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| CAMBRIDGE EPIGENETIX Ltd | — | Biotechnology | Series A | $12.3M | $444.4M | 2018 |
Timothy Rink at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Timothy Rink on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Somasundaram Subramaniam | 1 | 5 |
| Martin Murphy | 1 | 3 |
| Jason Mellad | 1 | 1 |
| Bobby Yerramilli-Rao | 1 | 1 |
| Alice Newcombe-Ellis | 1 | 1 |
| Thomas Hulme | 1 | 1 |
| Shankar Balasubramanian | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.